Abstract: The present disclosure provides a Paenibacillus strain, and a hemostatic polysaccharide produced by same and use thereof. In the present disclosure, a Paenibacillus sp. 1229 has a deposit number of CCTCC NO: M 2022553. A produced exopolysaccharide (EPS) Hemoadhican has a hemostatic function, and can be prepared as a hemostatic material in different dosage forms for different types of hemostasis. The hemostatic material has a high hemostatic speed, no need for applying pressures to the wound for a long time, safety and non-toxicity, desirable biocompatibility, and no requirement of removal after use. The material is suitable for the application of hemostasis in irregular bleeding such as solid organs in vitro or in vivo and diffuse bleeding.

Abstract: Oligosaccharide riclinoctaose is used in preparation of a drug for treating and/or preventing ischemia-reperfusion injury (IRI). The oligosaccharide riclinoctaose has a structural formula as follows: The oligosaccharide riclinoctaose can significantly relieve postoperative liver injury, kidney injury, and brain injury in ischemia-reperfusion mice.

Abstract: The present disclosure provides a heteropoly oligosaccharide and an application thereof in improving plant disease resistance. The heteropoly oligosaccharide includes seven D-glucose residues and one D-galactose residue.

Abstract: The present disclosure provides use of adenosine deaminase (ADA) and an ADA modifier in preparation of a medicament for wound repair in a patient with diabetes. It is found for the first time that the ADA (EC 3.5.4.4) and a polyethylene glycol-modified adenosine deaminase (PEG-ADA) have a significant improvement effect on wound repair of type-2 diabetic mice, and the ADA or the ADA modifier can be developed into a medicament for treating diabetic wounds.

Abstract: Oligosaccharide riclinoctaose is used in preparation of a drug for treating and/or preventing ischemia-reperfusion injury (IRI). The oligosaccharide riclinoctaose has a structural formula as follows: The oligosaccharide riclinoctaose can significantly relieve postoperative liver injury, kidney injury, and brain injury in ischemia-reperfusion mice.

Abstract: First and second coherent light beams of the same wavelength are propagated in opposite directions to interact on a sub-wavelength thickness metallic metamaterial layer which is structured with a periodicity such that there is a resonance matched to the wavelength of the coherent beams. The first beam is then able to modulate the intensity of the second beam by modulating the phase and/or intensity of the first beam. The interference of the counter- propagating beams can eliminate or substantially reduce Joule loss of light energy in the metamaterial layer or, on the contrary, can lead to a near total absorption of light, depending on the mutual phase and/or intensity of the interacting beams. A modulation is thus provided without using a non-linear effect.

Abstract: First and second coherent light beams of the same wavelength are propagated in opposite directions to interact on a sub-wavelength thickness metallic metamaterial layer which is structured with a periodicity such that there is a resonance matched to the wavelength of the coherent beams. The first beam is then able to modulate the intensity of the second beam by modulating the phase and/or intensity of the first beam. The interference of the counter- propagating beams can eliminate or substantially reduce Joule loss of light energy in the metamaterial layer or, on the contrary, can lead to a near total absorption of light, depending on the mutual phase and/or intensity of the interacting beams. A modulation is thus provided without using a non-linear effect.

Abstract: A non-linear optical device comprising a non-linear element made of a plasmonic material with a periodic structure having a period smaller than the wavelength of a non-linear process intrinsic to the plasmonic material. The plasmonic material is implemented as a gold film which is structured with a periodic array of asymmetric split ring slits. The metamaterial framework of the plasmonic material itself is used as the source of a strong and fast non-linearity. The cubic non-linear response is resonantly enhanced through the effect of the metamaterial structuring by more than two orders of magnitude and its sign and magnitude can be controlled by varying the metamaterial pattern.

Abstract: A method and a device are disclosed for changing the color of a metal surface in a given part of the electromagnetic spectrum. It is achieved by creating a surface relief as an array of raised or indented repeated elements without breaking the continuity of the metal surface. The characteristic size of the elements is smaller than the shortest wavelength in that part of spectrum. In particular, the method uses excitation of surface plasmons on the metal surface. The relief may be optionally covered by a layer of dielectric or semiconductor for further fixed or externally controlled change of the metal surface color. The device may be used to detect the intensity or color or phase of incident light. It may be used to detect another substance in proximity of the surface by changing the color or phase or intensity of reflected light.

Abstract: The present invention relates to the discovery the 5?-AMP and analogues thereof can be used to induce a state of torpor or suspended animation in subjects, as exemplified by studies carried out in laboratory mice. In these studies; mice were injected with high doses of 5?-AMP, which was found to result in a decoupling of the animals' body temperature regulation mechanism accompanied by a reduction in the animals' core body temperature, which tended to lower towards the ambient environmental temperature. It was further discovered that the introduction of high levels of 5?-AMP resulted in an induction of fat regulation genes such as procolipase (Clps) in tissues and organs that do not normally express Clps, this in turn was accompanied by a shift in metabolism from a primarily glycolytic energy metabolism (which is inhibited at lower temperatures) to one that relied primarily on the liberation and metabolism of free fatty acids.

Abstract: The present invention relates to the discovery the 5?-AMP and analogues thereof can be used to induce a state of torpor or suspended animation in subjects, as exemplified by studies carried out in laboratory mice. In these studies, mice were injected with high doses of 5?-AMP, which was found to result in a decoupling of the animals' body temperature regulation mechanism accompanied by a reduction in the animals' core body temperature, which tended to lower towards the ambient environmental temperature. It was further discovered that the introduction of high levels of 5?-AMP resulted in an induction of fat regulation genes such as procolipase (Clps) in tissues and organs that do not normally express Clps, this in turn was accompanied by a shift in metabolism from a primarily glycolytic energy metabolism (which is inhibited at lower temperatures) to one that relied primarily on the liberation and metabolism of free fatty acids.